• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓栓塞事件作为 IIIB 期宫颈癌患者生存的预后因素。

Thromboembolic event as a prognostic factor for the survival of patients with stage IIIB cervical cancer.

机构信息

Instituto Nacional de Câncer, Ministério da Saúde, Rio de Janeiro, Brazil.

出版信息

Int J Gynecol Cancer. 2011 May;21(4):706-10. doi: 10.1111/IGC.0b013e3181f87d69.

DOI:10.1111/IGC.0b013e3181f87d69
PMID:21546873
Abstract

OBJECTIVE

The purpose of this study was to evaluate the effect of thromboembolic event (TEE) on the prognosis and survival of women diagnosed with the International Federation of Gynecology and Obstetrics (FIGO) stage IIIB cervical cancer undergoing treatment at the National Cancer Institute (Instituto Nacional de Câncer [INCA], Ministério da Saúde), Brazil.

METHODS

A total of 1020 women with FIGO stage IIIB cervical cancer (International Classification of Diseases, C53.9), who had received treatment at this institute between 2000 and 2004, were identified. Data were obtained from the hospital cancer registry at INCA. Patients were followed up from the date of their diagnosis of cervical cancer at INCA until their death or last follow-up visit. The date of TEE diagnosis was defined as the date of one of the following tests diagnosing this condition: Doppler ultrasound scan, computed tomography scan, or in 1 single case echocardiography. The Kaplan-Meyer method was used to perform long-term survival analysis.

CONCLUSIONS

The presence of TEE in patients with FIGO stage IIIB cervical cancer seems to be indicative of the severity of the disease and poorer prognosis. The most important finding is that in the patients who developed TEE, this complication occurred around the time of diagnosis of progression of the disease. Disease progression may have been the triggering factor for the development of TEE.

摘要

目的

本研究旨在评估血栓栓塞事件(TEE)对在巴西国家癌症研究所(INCA,卫生部)接受治疗的国际妇产科联合会(FIGO)分期为 IIIB 期宫颈癌女性的预后和生存的影响。

方法

共确定了 1020 名在该研究所接受治疗的 FIGO 分期为 IIIB 期宫颈癌(国际疾病分类,C53.9)的女性。数据来自 INCA 医院癌症登记处。患者从 INCA 诊断为宫颈癌之日起接受随访,直至死亡或最后一次随访。TEE 诊断日期定义为以下诊断该疾病的检查之一的日期:多普勒超声扫描、计算机断层扫描或在 1 个病例中超声心动图。采用 Kaplan-Meier 方法进行长期生存分析。

结论

FIGO 分期为 IIIB 期宫颈癌患者存在 TEE 似乎表明疾病严重程度和预后较差。最重要的发现是,在发生 TEE 的患者中,这种并发症发生在疾病进展诊断的时间左右。疾病进展可能是 TEE 发展的触发因素。

相似文献

1
Thromboembolic event as a prognostic factor for the survival of patients with stage IIIB cervical cancer.血栓栓塞事件作为 IIIB 期宫颈癌患者生存的预后因素。
Int J Gynecol Cancer. 2011 May;21(4):706-10. doi: 10.1111/IGC.0b013e3181f87d69.
2
Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.评价 2018 年 FIGO 分期中局部晚期宫颈癌 IIIB 期患者在同期放化疗中预防性扩大野照射的疗效。
Radiat Oncol. 2019 Dec 16;14(1):228. doi: 10.1186/s13014-019-1431-9.
3
Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.2018 年国际妇产科联合会宫颈癌分期指南的预后性能。
Obstet Gynecol. 2019 Jul;134(1):49-57. doi: 10.1097/AOG.0000000000003311.
4
Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.顺铂化疗联合放疗与单纯放疗治疗 FIGO 分期为 IIIB 期的子宫颈鳞状细胞癌的随机临床试验。
JAMA Oncol. 2018 Apr 1;4(4):506-513. doi: 10.1001/jamaoncol.2017.5179.
5
Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.对于FIGO IIIB/IVA期宫颈癌患者,采用化疗放疗后序贯含紫杉醇和卡铂的巩固化疗。
J Gynecol Oncol. 2017 Jan;28(1):e15. doi: 10.3802/jgo.2017.28.e15.
6
Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.国际妇产科联合会(FIGO)IA2 期至 IIA 期宫颈癌中转移淋巴结的绝对数量和比值对预测术后生存的意义。
Int J Gynecol Cancer. 2013 Jan;23(1):157-63. doi: 10.1097/IGC.0b013e3182778bcf.
7
Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.评估 F-18 氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在 IIIB 期宫颈癌患者分期中的作用及其对治疗决策的影响。
Int J Gynecol Cancer. 2018 Feb;28(2):379-384. doi: 10.1097/IGC.0000000000001174.
8
Clinical profile and treatment outcome of collision carcinoma in cervix.子宫颈碰撞癌的临床特征与治疗结果
Medicine (Baltimore). 2020 Mar;99(11):e19131. doi: 10.1097/MD.0000000000019131.
9
Pretreatment Mean Apparent Diffusion Coefficient Is Significantly Correlated With Event-Free Survival in Patients With International Federation of Gynecology and Obstetrics Stage Ib to IIIb Cervical Cancer.在国际妇产科联盟(FIGO) Ib 期至 IIIb 期宫颈癌患者中,预处理平均表观扩散系数与无事件生存期显著相关。
Int J Gynecol Cancer. 2015 Jul;25(6):1079-85. doi: 10.1097/IGC.0000000000000445.
10
Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.2003年至2012年国际妇产科联盟IIb期宫颈癌的治疗结果:治疗与预后评估:一项回顾性研究
Int J Gynecol Cancer. 2015 Jun;25(5):910-8. doi: 10.1097/IGC.0000000000000430.

引用本文的文献

1
[Not Available].[无可用内容]
J Vasc Bras. 2017 Oct-Dec;16(4):308-313. doi: 10.1590/1677-5449.007817.